Surface Oncology to Present at the UBS Virtual Global Healthcare Conference
CAMBRIDGE, Mass., May 13, 2020 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that […]